Rein Therapeutics, Inc.
RNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420565
No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Rein Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −4 vs. Q2 2021
- Shares held
- 32.9M
- −287.5K (−0.9%) vs. Q2 2021
- Total value
- $33.6M
- −$7.93M (−19.1%) vs. Q2 2021
- New holders
- 5
- 11 more added
- Sold out
- 9
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $42.3M |
| Q1 2026 | 46 | $14.8M |
| Q4 2025 | 48 | $12.5M |
| Q3 2025 | 40 | $9.76M |
| Q2 2025 | 36 | $9.30M |
| Q1 2025 | 39 | $10.6M |
| Q4 2024 | 31 | $13.1M |
| Q3 2024 | 32 | $16.3M |
| Q2 2024 | 29 | $13.5M |
| Q1 2024 | 23 | $11.0M |
| Q4 2023 | 20 | $3.24M |
| Q3 2023 | 16 | $1.59M |
| Q2 2023 | 17 | $1.83M |
| Q1 2023 | 19 | $1.30M |
| Q4 2022 | 19 | $3.21M |
| Q3 2022 | 33 | $5.86M |
| Q2 2022 | 37 | $8.34M |
| Q1 2022 | 42 | $16.5M |
| Q4 2021 | 43 | $18.9M |
| Q3 2021 | 43 | $33.6M |
| Q2 2021 | 47 | $41.5M |
| Q1 2021 | 52 | $48.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 405 | $0 | 0.00% | −48−10.6% | Reduced |
| Allworth Financial LP | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Jacobi Capital Management LLC | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,684 | $8.00K | 0.00% | −4,011−34.3% | Reduced |
| Ridgecrest Wealth Partners, LLC | 10,000 | $10.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 11,239 | $11.0K | 0.00% | −495−4.2% | Reduced |
| Kore Private Wealth LLC | 11,183 | $11.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 11,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 16,625 | $17.0K | 0.00% | +6,291+60.9% | Added |
| Lake Street Advisors Group, LLC | 18,500 | $19.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 19,290 | $19.0K | 0.00% | +19,290 | New |
| Mercer Global Advisors Inc | 20,997 | $21.0K | 0.00% | 00.0% | Unchanged |
| Meitav Dash Investments Ltd | 21,000 | $21.0K | 0.00% | +10,000+90.9% | Added |
| Two Sigma Securities, LLC | 22,852 | $23.0K | 0.00% | +22,852 | New |
| PVG Asset Management Corp | 23,555 | $24.0K | 0.07% | +8,550+57.0% | Added |
| US Bancorp | 25,000 | $26.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 25,279 | $26.0K | 0.00% | +17,743+235.4% | Added |
| Qube Research & Technologies Ltd | 25,279 | $26.0K | 0.00% | +25,279 | New |
| Personal Cfo Solutions, LLC | 30,500 | $31.0K | 0.01% | −3,000−9.0% | Reduced |
| Kestra Advisory Services, LLC | 30,000 | $31.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 30,093 | $31.0K | 0.00% | +6,993+30.3% | Added |
| JFS Wealth Advisors, LLC | 31,807 | $32.0K | 0.00% | +31,807 | New |
| Morgan Stanley | 48,452 | $50.0K | 0.00% | +10,730+28.4% | Added |
| Envestnet Asset Management Inc | 54,176 | $55.0K | 0.00% | +19,522+56.3% | Added |
| Millennium Management LLC | 57,116 | $58.0K | 0.00% | −4,719−7.6% | Reduced |
| State Street Corp | 71,200 | $73.0K | 0.00% | 00.0% | Unchanged |
| Morgan Jess S & Co Inc | 75,000 | $76.0K | 0.05% | 00.0% | Unchanged |
| Keebeck Wealth Management, LLC | 76,000 | $78.0K | 0.02% | −79,627−51.2% | Reduced |
| Wade G W & Inc | 100,993 | $103.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 127,883 | $130.0K | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 127,000 | $130.0K | 0.08% | +27,000+27.0% | Added |
| Taconic Capital Advisors LP | 135,000 | $138.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 180,933 | $185.0K | 0.02% | +180,933 | New |
| BlackRock Inc. | 194,529 | $198.0K | 0.00% | −4,128−2.1% | Reduced |
| Boothbay Fund Management, LLC | 312,325 | $319.0K | 0.01% | −80,690−20.5% | Reduced |
| AJU IB Investment Co., Ltd. | 517,558 | $528.0K | 0.34% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 734,721 | $749.0K | 0.00% | −296,407−28.7% | Reduced |
| Blair William & Co | 803,160 | $819.0K | 0.00% | +115,116+16.7% | Added |
| Geode Capital Management, LLC | 822,946 | $839.0K | 0.00% | +56,133+7.3% | Added |
| Ikarian Capital, LLC | 2,763,583 | $2.82M | 0.65% | −36,417−1.3% | Reduced |
| Vanguard Group Inc | 3,444,971 | $3.51M | 0.00% | +4,338+0.1% | Added |
| BVF Inc | 5,265,555 | $5.37M | 0.21% | 00.0% | Unchanged |
| Satter Management Co., L.P. | 16,609,449 | $16.9M | 11.60% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −124,800−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −77,405−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −30,223−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −27,406−100.0% | Sold out |
| Hollow Brook Wealth Management LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −22,556−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −10,391−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,715−100.0% | Sold out |